Tromantadine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Tromantadine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Drugbox|
{{Drugbox
|IUPAC_name = ''N''-1-adamantyl-''N''-[2-(dimethylamino)ethoxy]acetamide
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470617884
| IUPAC_name = ''N''-1-adamantyl-''N''-[2-(dimethylamino)ethoxy]acetamide
| image = Tromantadine.png
| image = Tromantadine.png
| CAS_number=53783-83-8
| alt = Skeletal formula
| ATC_prefix=D06
| image2 = Tromantadine-3D-balls.png
| ATC_suffix=BB02  
| alt2 = Ball-and-stick model
| PubChem=64377
<!--Clinical data-->
| DrugBank=
| tradename = 
| C = 16 |H = 28 |N = 2 |O = 2
| Drugs.com = {{drugs.com|international|tromantadine}}
| pregnancy_category = 
| legal_status = 
| routes_of_administration = [[Topical]]
 
<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| excretion = 
 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 53783-83-8
| ATC_prefix = D06
| ATC_suffix = BB02
| ATC_supplemental = {{ATC|J05|AC03}}
| PubChem = 64377
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 57947
| NIAID_ChemDB = 007760
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = H191JFG8WA
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07199
 
<!--Chemical data-->
| C=16 | H=28 | N=2 | O=2  
| molecular_weight = 280.406 [[Gram|g]]/[[Mole (unit)|mol]]
| molecular_weight = 280.406 [[Gram|g]]/[[Mole (unit)|mol]]
| smiles = O=C(C)N(OCCN(C)C)C23CC1CC(C3)CC(C2)C1
| smiles = O=C(NC13CC2CC(CC(C1)C2)C3)COCCN(C)C
| bioavailability=  
| InChI = 1/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)
| metabolism =  
| InChIKey = UXQDWARBDDDTKG-UHFFFAOYAP
| elimination_half-life=
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| excretion =
| StdInChI = 1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)
| pregnancy_category =
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| legal_status =
| StdInChIKey = UXQDWARBDDDTKG-UHFFFAOYSA-N
| routes_of_administration= [[Topical]]
}}
}}
'''Tromantadine''' is an [[antiviral]] [[medicine]] used to treat [[herpes simplex virus]]. It is available in a topical [[gel]] under trade name '''Viru-Merz'''. Its performance is similar to [[aciclovir]].
              __NOTOC__
{{SI}}
{{CMG}}


Tromantadine inhibits the early and late events in the [[virus]] replication cycle. It changes the [[glycoprotein]]s of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents [[uncoating]] of the [[virion]]s.
 
==Overview==
   
'''Tromantadine''' is an antiviral medicine used to treat [[herpes simplex virus]]. It is available in a topical [[gel]] under trade name '''Viru-Merz'''. Its performance is similar to [[aciclovir]].


Like [[rimantadine]] and [[amantadine]], tromantadine is a derivative of [[adamantane]].
Like [[rimantadine]] and [[amantadine]], tromantadine is a derivative of [[adamantane]].
==Mechanism==
Tromantadine inhibits the early and late events in the [[virus]] replication cycle.<ref name="pmid6297383">{{cite journal |author=Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC |title=Tromantadine: inhibitor of early and late events in herpes simplex virus replication |journal=Antimicrob. Agents Chemother. |volume=22 |issue=6 |pages=1031–6 |date=December 1982 |pmid=6297383 |pmc=185716 |doi= 10.1128/aac.22.6.1031|url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=6297383}}</ref> It changes the [[glycoprotein]]s of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents [[uncoating]] of the [[virion]]s.
==References==
{{reflist|2}}


==External links==
==External links==
*[http://www.brookespharma.com/brands_virumerz_main.htm Viru-Merz website]
*[http://www.brookespharma.com/brands_virumerz_main.htm Viru-Merz website]


{{antimicrobial-stub}}
{{Antibiotics and chemotherapeutics for dermatological use}}
{{Antibiotics and chemotherapeutics for dermatological use}}
{{Antivirals}}
{{Antivirals}}
[[Category:Antivirals]]
 
[[Category:Drug]]
[[Category:Amines]]

Latest revision as of 15:12, 10 April 2015

Tromantadine
Skeletal formula
Ball-and-stick model
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
NIAID ChemDB
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H28N2O2
Molar mass280.406 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Tromantadine

Articles

Most recent articles on Tromantadine

Most cited articles on Tromantadine

Review articles on Tromantadine

Articles on Tromantadine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tromantadine

Images of Tromantadine

Photos of Tromantadine

Podcasts & MP3s on Tromantadine

Videos on Tromantadine

Evidence Based Medicine

Cochrane Collaboration on Tromantadine

Bandolier on Tromantadine

TRIP on Tromantadine

Clinical Trials

Ongoing Trials on Tromantadine at Clinical Trials.gov

Trial results on Tromantadine

Clinical Trials on Tromantadine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tromantadine

NICE Guidance on Tromantadine

NHS PRODIGY Guidance

FDA on Tromantadine

CDC on Tromantadine

Books

Books on Tromantadine

News

Tromantadine in the news

Be alerted to news on Tromantadine

News trends on Tromantadine

Commentary

Blogs on Tromantadine

Definitions

Definitions of Tromantadine

Patient Resources / Community

Patient resources on Tromantadine

Discussion groups on Tromantadine

Patient Handouts on Tromantadine

Directions to Hospitals Treating Tromantadine

Risk calculators and risk factors for Tromantadine

Healthcare Provider Resources

Symptoms of Tromantadine

Causes & Risk Factors for Tromantadine

Diagnostic studies for Tromantadine

Treatment of Tromantadine

Continuing Medical Education (CME)

CME Programs on Tromantadine

International

Tromantadine en Espanol

Tromantadine en Francais

Business

Tromantadine in the Marketplace

Patents on Tromantadine

Experimental / Informatics

List of terms related to Tromantadine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Tromantadine is an antiviral medicine used to treat herpes simplex virus. It is available in a topical gel under trade name Viru-Merz. Its performance is similar to aciclovir.

Like rimantadine and amantadine, tromantadine is a derivative of adamantane.

Mechanism

Tromantadine inhibits the early and late events in the virus replication cycle.[1] It changes the glycoproteins of the host cells, therefore impeding the absorption of the virus. It inhibits penetration of the virus. It also prevents uncoating of the virions.

References

  1. Rosenthal KS, Sokol MS, Ingram RL, Subramanian R, Fort RC (December 1982). "Tromantadine: inhibitor of early and late events in herpes simplex virus replication". Antimicrob. Agents Chemother. 22 (6): 1031–6. doi:10.1128/aac.22.6.1031. PMC 185716. PMID 6297383.

External links